Clinical Trials
2 trialsNCT04502030 2026-06-04
Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)
Octapharma
Phase 3 Completed
NCT06224309 2026-06-03
Preliminary Assessment of [18F]BL40 in PET/CT Scans
British Columbia Cancer Agency
Completed